198 related articles for article (PubMed ID: 7809097)
1. Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives.
Cai RZ; Reile H; Armatis P; Schally AV
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12664-8. PubMed ID: 7809097
[TBL] [Abstract][Full Text] [Related]
2. Pseudononapeptide bombesin antagonists containing C-terminal Trp or Tpi.
Cai RZ; Radulovic S; Pinski J; Nagy A; Redding TW; Olsen DB; Schally AV
Peptides; 1992; 13(2):267-71. PubMed ID: 1409006
[TBL] [Abstract][Full Text] [Related]
3. New antagonists of bombesin gastrin-releasing Peptide with C-terminal leu-psi-(ch2n)tac-nh2.
Reile H; Cai R; Armatis P; Schally A
Int J Oncol; 1995 Oct; 7(4):749-54. PubMed ID: 21552898
[TBL] [Abstract][Full Text] [Related]
4. New pseudononapeptide bombesin antagonists with C-terminal leu-psi(ch2n)tac-nh2 show high binding-affinity to bombesin/grp receptors on cfpac-1 human pancreatic-cancer cells.
Cai R; Qin Y; Ertl T; Schally A
Int J Oncol; 1995 Jun; 6(6):1165-72. PubMed ID: 21556653
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.
Nagy A; Armatis P; Cai RZ; Szepeshazi K; Halmos G; Schally AV
Proc Natl Acad Sci U S A; 1997 Jan; 94(2):652-6. PubMed ID: 9012839
[TBL] [Abstract][Full Text] [Related]
6. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi.
Radulovic S; Cai RZ; Serfozo P; Groot K; Redding TW; Pinski J; Schally AV
Int J Pept Protein Res; 1991 Dec; 38(6):593-600. PubMed ID: 1726427
[TBL] [Abstract][Full Text] [Related]
7. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity.
Coy DH; Taylor JE; Jiang NY; Kim SH; Wang LH; Huang SC; Moreau JP; Gardner JD; Jensen RT
J Biol Chem; 1989 Sep; 264(25):14691-7. PubMed ID: 2475489
[TBL] [Abstract][Full Text] [Related]
8. Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells.
Wang LH; Coy DH; Taylor JE; Jiang NY; Kim SH; Moreau JP; Huang SC; Mantey SA; Frucht H; Jensen RT
Biochemistry; 1990 Jan; 29(3):616-22. PubMed ID: 1692477
[TBL] [Abstract][Full Text] [Related]
9. Development of potent gastrin-releasing peptide antagonists having a D-Pro-psi(CH2NH)-Phe-NH2 C terminus.
Leban JJ; Kull FC; Landavazo A; Stockstill B; McDermed JD
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1922-6. PubMed ID: 8446610
[TBL] [Abstract][Full Text] [Related]
10. Potent bombesin receptor antagonists distinguish receptor subtypes.
von Schrenck T; Wang LH; Coy DH; Villanueva ML; Mantey S; Jensen RT
Am J Physiol; 1990 Sep; 259(3 Pt 1):G468-73. PubMed ID: 2169207
[TBL] [Abstract][Full Text] [Related]
11. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
[TBL] [Abstract][Full Text] [Related]
12. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
[TBL] [Abstract][Full Text] [Related]
13. Conveyance of partial agonism/antagonism to bombesin/gastrin-releasing peptide analogues on Swiss 3T3 cells by a carboxyl-terminal leucine insertion.
Kull FC; Leban JJ; Landavazo A; Stewart KD; Stockstill B; McDermed JD
J Biol Chem; 1992 Oct; 267(29):21132-8. PubMed ID: 1400423
[TBL] [Abstract][Full Text] [Related]
14. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
Narayan S; Spindel ER; Rubin NH; Singh P
Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of peptide and pseudopeptide amides inhibiting the proliferation of small cell and epithelial types of lung carcinoma cells.
Nyéki O; Rill A; Schon I; Orosz A; Schrett J; Bartha L; Nagy J
J Pept Sci; 1998 Dec; 4(8):486-95. PubMed ID: 9927255
[TBL] [Abstract][Full Text] [Related]
16. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
Wu JM; Hoang DO; Feldman RI
Mol Pharmacol; 1995 Apr; 47(4):871-81. PubMed ID: 7723750
[TBL] [Abstract][Full Text] [Related]
17. Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells.
Dietrich JB; Hildebrand P; Jeker LB; Pansky A; Eberle AN; Beglinger C
Regul Pept; 1994 Oct; 53(3):165-73. PubMed ID: 7531356
[TBL] [Abstract][Full Text] [Related]
18. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
Halmos G; Schally AV
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):956-60. PubMed ID: 9023364
[TBL] [Abstract][Full Text] [Related]
19. Systematic development of bombesin/gastrin-releasing peptide antagonists.
Coy DH; Jensen RT; Jiang NY; Lin JT; Bogden AE; Moreau JP
J Natl Cancer Inst Monogr; 1992; (13):133-9. PubMed ID: 1389686
[TBL] [Abstract][Full Text] [Related]
20. Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors.
González N; Mantey SA; Pradhan TK; Sancho V; Moody TW; Coy DH; Jensen RT
Peptides; 2009 Aug; 30(8):1473-86. PubMed ID: 19463875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
